ARCHIVES

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 35 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Goofs On Contract Notice, Won’t Change Improper Deadline

April 15, 1977

Study Supports Immediate Breast Reconstruction

September 24, 2004

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Lurie Center At Northwestern Wins Core Grant Renewal.

December 7, 2001

Pao Named Director of Department Of Hematology And Oncology At Vanderbilt University

September 30, 2011

In Brief: Angel Bradley, NCAB Member, Dies; Three State Colorectal Cancer Screening Effort Big Success

July 5, 1985